Light therapy for sickle cell disease in children and teens
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests a light-based therapy called transcranial photobiomodulation to see if it can help people with sickle cell disease. It is for children and teens aged 8 to 17 who are part of the SCCRIP study and have not had certain brain complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have sickle cell disease (any type) and be part of the SCCRIP study program.
- Your age must be between 8 and 17 years old.
- You must speak English and be willing to participate with your parent or guardian's consent.
- You cannot have had an abnormal transcranial doppler test, a silent stroke, a brain injury, or a stroke.
- You must not have had a blood transfusion within the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental gene therapy called CS-206 for teenagers with sickle cell disease. It aims to help reduce severe complications by modifying the patient's own blood stem cells.
This trial tests CS-206, an experimental therapy for people with sickle cell disease. It aims to reduce severe complications like pain crises, acute chest syndrome, strokes, and other serious events. You may qualify if you have a specific genetic type of sickle cell disease and have experienced complications despite standard treatments.
This trial is testing a digital program to help improve working memory (the ability to hold and use information in your mind) for children with sickle cell disease. If you join, you'll use a computer-based training program at home and researchers will see if it works and is easy to use.
This trial is testing a new, gentler type of bone marrow transplant for children and young adults with sickle cell disease who have a healthy sibling donor with a mismatched blood type or who have antibodies against their donor's red blood cells. The goal is to replace the faulty bone marrow with healthy donor cells, with fewer side effects than traditional transplants.
This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.
This trial tests if EMDR therapy can help children with sickle cell disease reduce pain interference in daily life. If you or your child has sickle cell disease and experiences significant pain, this study may offer a new way to manage it.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.